Stay updated on Mepolizumab Efficacy in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab Efficacy in Severe Asthma Clinical Trial page.

Latest updates to the Mepolizumab Efficacy in Severe Asthma Clinical Trial page
- Check5 days agoChange DetectedThe clinical study record is now displayed for a Brazilian phase IV study evaluating mepolizumab for severe eosinophilic asthma. It includes trial design, eligibility criteria, outcome measures, study contacts, and location details.SummaryDifference49%

- Check12 days agoChange DetectedThe footer's ClinicalTrials.gov software revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH announcement about updated terminology appears above the 403 error page, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study content. The header and footer render as a standard ClinicalTrials.gov 403 page indicating blocked access.SummaryDifference0.5%

- Check54 days agoChange DetectedThe study record page now displays a 403 error with a simple header and a Home link, replacing the full details of the NCT04228588 study.SummaryDifference18%

Stay in the know with updates to Mepolizumab Efficacy in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab Efficacy in Severe Asthma Clinical Trial page.